Bill & Melinda Gates Foundation’s “Impatient Optimists”: We Must End Global Disparities for Mothers and Children
Dagfinn Høybråten, chair of the Board of Gavi, The Vaccine Alliance, discusses the importance of ending disparities in vaccine coverage and writes, “Gavi is now embarking on a goal to increase to 50 percent from five percent the number of children who receive all 11 vaccines recommended by World Health Organization. By doing so, we expect to save five million to six million more lives…” (5/18).
Share -->PrintHomeGlobal Health PolicyKaiser Daily Global Health Policy ReportMay 19, 2015Ending Disparity In Vaccine Coverage Will Save More LivesMay 19, 2015
Share -->PrintHomeGlobal Health PolicyKaiser Daily Global Health Policy ReportMay 19, 2015U.S. Must Maintain Investments In HIV Vaccine, Prevention ResearchMay 19, 2015
The Hill: Choosing the worst time to scale back AIDS research
Mitchell Warren, executive director of AVAC
“…For the first time, we can honestly talk about how to end the AIDS epidemic — and we have not only researchers, advocates, and trial participants to thank, but also American taxpayers. But we don’t yet have all the tools we need. That’s why it is dismaying that some members of Congress have chosen this moment to call for scaling back the nation’s investments in HIV research. Instead, we should be looking for ways to make these investments even more impactful, to continue leading the world into a future without AIDS…” (5/18).
Share -->PrintHomeGlobal Health PolicyKaiser Daily Global Health Policy ReportMay 18, 2015Recent Scientific Advances Bring Hope To Search For HIV Vaccine, UNAIDS Head SaysMay 18, 2015
UNAIDS: UNAIDS calls for sustained commitment to develop an effective HIV vaccine
“On HIV Vaccine Awareness Day, UNAIDS is calling for a renewed global commitment to finding an effective HIV vaccine. ‘A vaccine would be a major step towards ending the AIDS epidemic,’ said UNAIDS Executive Director Michel Sidibé. ‘There have been encouraging recent scientific advances that give us hope for the future development of an HIV vaccine’…” (5/18).
Share -->PrintHomeGlobal Health PolicyKaiser Daily Global Health Policy ReportMay 13, 2015FDA Examines Process For Approving Ebola Vaccine In Light Of Waning OutbreakMay 13, 2015
CQ HealthBeat: FDA Weighs Process for Approving Ebola Vaccine
“A Food and Drug Administration advisory panel on Tuesday tackled difficult questions on the development of a vaccine for the Ebola virus although the outbreak, which has killed more than 11,000 people, has subsided. … While that comes as good news for public health, it presents a challenge for drug development and for regulators who now need to look at other data, potentially from animal studies, as it reviews potential vaccines…” (Gustin, 5/12).
